Standard Biotools (LAB) EBITDA Margin (QoQ) (2010 - 2026)
Standard Biotools (LAB) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,719.00 |
| Mar 31, 2026 | 4,447.00 |
| Dec 31, 2025 | 6,490.00 |
| Sep 30, 2025 | -5,038.00 |
| Jun 30, 2025 | 1,529.00 |
| Mar 31, 2025 | -2,810.00 |
| Dec 31, 2024 | 1,562.00 |
| Sep 30, 2024 | 1,365.00 |
| Jun 30, 2024 | -239.00 |
| Mar 31, 2024 | -5,628.00 |
| Dec 31, 2023 | 759.00 |
| Sep 30, 2023 | -2,039.00 |
| Jun 30, 2023 | 299.00 |
| Mar 31, 2023 | 1,207.00 |
| Dec 31, 2022 | 3,505.00 |
| Sep 30, 2022 | 9,219.00 |
| Jun 30, 2022 | -10,160.00 |
| Sep 30, 2021 | -354.00 |
| Jun 30, 2021 | 158.00 |
| Mar 31, 2021 | -2,102.00 |